Artivion

Artivion, Inc. (NYSE: AORT) is a prominent entity in the Medical Devices & Equipment and Manufacturing sectors, established in 1984. The company specializes in the manufacturing, processing, and distribution of advanced medical devices and implantable tissues. Its primary focus is on solutions for cardiac and vascular surgical procedures, particularly those aimed at aortic repair. Artivion's product portfolio includes critical components such as medical devices, stents, grafts, heart valves, implantable human tissues, sealants, and mechanical valves designed to address various cardiovascular diseases. With a global presence indicated by its location count of 3, Artivion serves a vital role in the healthcare supply chain, providing essential tools for complex surgical interventions.

The company operates with a substantial workforce, falling within the employee range of 1,000 - 5,000 individuals. This scale of operation supports its mission to deliver innovative medical solutions. Artivion's commitment to its team and operational excellence is a key factor in its market position. For insights into the people driving its innovation and operations, one can explore Meet Artivion's team. The company's strategic approach involves developing and distributing products that meet stringent medical standards, ensuring efficacy and patient safety in critical surgical applications.

Artivion generated a revenue of $458.7 million, underscoring its significant market presence and financial standing within the medical technology industry. Its competitive landscape includes companies like Genesis MedTech and LSI Solutions, highlighting the dynamic nature of the medical device market. The company's dedication to advancing treatments for aortic repair and other cardiovascular conditions positions it as a key player,View more...